IFNG and myeloid sarcoma: In progressive MS patients, improving symptoms correlated with high levels of serum IFNγ, while patients with clinical worsening had relatively low levels of serum IFNγ [37], suggesting IFNγ-induced iP expression may have a role in MS stabilization or even recovery.